Premier Integrated Platform in APAC to Develop Innovative Therapies for Oncology Antengene Corporation Limited...

Antengene's listing ceremony in Shanghai: Dr. Jay Mei, M.D., Ph.D., founder, Chairman and CEO (Left); Mr. Yiteng Liu, M.Sc., Chief Operating Officer (Right) Antengene...

Bintai Kinden Corporation Berhad Emerges as Substantial Shareholder in Malaysian Genomics Resource Centre Berhad

Malaysian Genomics Resource Centre Berhad ("MGRC" or "the Group"), a leading genomics and biopharmaceutical specialist, is pleased to announce the entry of a new...
Agilex Tetra

Agilex Biolabs acquires leading biolab TetraQ for APAC Expansion Plans

Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced the acquisition of leading biolab TetraQ, based at...

Jacobson Pharma Announces FY2022 Interim Results

Robust Growth of 11.6% in Generics Business Amidst the Pandemic Confident about Sustaining Strong Growth Momentum Declares Interim Dividend of HK1.2 Cents Per...

Avantor Named Best Company in Bioprocessing Excellence for Single-use Solutions and Best Bioprocessing Supplier...

Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies and applied materials industries, was...

Hua Medicine Successfully Completes Its Registration Phase III Trials; Announces 52-Week Results for DAWN...

Hua Medicine (HKG:2552), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, today announced: Successfully completes two...

Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution...

Aptorum Group Limited ("Aptorum Group"), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the commercialization...

Join Asia’s Pharma & Biotech Festival in Singapore

Singapore, Dec 9, 2019 - (ACN Newswire) - The third edition of Phar-East is back once again in Singapore on March 31-April 1, 2020 at Resorts World Convention...

New Horizon Health Announces 2021 Interim Results: Revenue Increases 317% Year-on-year, Gross Profit Margin...

New Horizon Health (HKG:6606) (the Company), the first public listed cancer screening company in China, has today announced its financial report for the first...

Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed...

Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the abstracts on...

Tiny electric generators could accelerate wound healing

Researchers are working to overcome challenges in order to bring wearable, electric, wound-healing devices to clinical practice. Tiny dressings that generate electricity in response to...
EC Healthcare

EC Healthcare expects sales volume to increase 35% Y-o-Y to no less than HK$3...

EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital medical group in Hong...

APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid...

Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and GlycoMimetics (Nasdaq: GLYC), today announced...

Malaysian Genomics Resource Centre Berhad Supports Yayasan Seri Negara’s Ramadhan Initiative

Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to support Yayasan Seri Negara's (YSN) Ihya Ramadhan...

Theragen Bio analyzes Korea’s largest COVID-19 patient and coronavirus genomic data

Theragen Bio is conducting joint research on developing a new coronavirus (COVID-19) genomic big data in collaboration with the Korea Research Institute of Chemical...

Sirnaomics Ltd., the RNA Therapeutics Biopharmaceutical Company with Strong Presence in Both China and...

Sirnaomics Ltd. ("Sirnaomics" or "Company", together with its subsidiaries, the "Group", stock code: 2257.HK), the RNA therapeutics biopharmaceutical company with strong presence in both...

Maculus Therapeutix welcomes Privity FZ LLE and Prepares Capital Raise for Novel Drug Delivery...

Maculus Therapeutix, a preclinical-stage biopharmaceutical company which has developed a SINGLE injection delivery platform for diseases such as wet AMD (Age-related Macular Degeneration) and...

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China –...

Hua Medicine (Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was...

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to...

Scivita Medical Technology Co., Ltd. ("civita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become...

Cryoviva Singapore Gets AABB Accreditation for Somatic Cells’ Processing, Storage, and Distribution

Family cord blood bank Cryoviva Singapore is pleased to announce that it has now been accredited by the Association of the Advancement of Blood...